CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis
TSX:CHR - Toronto Stock Exchange - CA17040T3001 - Common Stock - Currency: CAD
CHR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 9 industry peers in the Passenger Airlines industry. CHR has only an average score on both its financial health and profitability. CHR has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CHR has reported negative net income.
CHR had a positive operating cash flow in the past year.
In multiple years CHR reported negative net income over the last 5 years.
In the past 5 years CHR always reported a positive cash flow from operatings.
1.2 Ratios
CHR has a Return On Assets of -16.53%. This is comparable to the rest of the industry: CHR outperforms 44.44% of its industry peers.
CHR's Return On Equity of -51.90% is in line compared to the rest of the industry. CHR outperforms 44.44% of its industry peers.
CHR has a Return On Invested Capital of 6.82%. This is amongst the best in the industry. CHR outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHR is in line with the industry average of 6.12%.
The 3 year average ROIC (5.30%) for CHR is below the current ROIC(6.82%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -16.53% | ||
| ROE | -51.9% | ||
| ROIC | 6.82% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
1.3 Margins
The Operating Margin of CHR (6.78%) is better than 66.67% of its industry peers.
In the last couple of years the Operating Margin of CHR has declined.
CHR's Gross Margin of 64.61% is amongst the best of the industry. CHR outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of CHR has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.78% | ||
| PM (TTM) | N/A | ||
| GM | 64.61% |
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHR is destroying value.
Compared to 1 year ago, CHR has less shares outstanding
The number of shares outstanding for CHR has been reduced compared to 5 years ago.
CHR has a better debt/assets ratio than last year.
2.2 Solvency
CHR has an Altman-Z score of 0.65. This is a bad value and indicates that CHR is not financially healthy and even has some risk of bankruptcy.
CHR has a Altman-Z score of 0.65. This is in the lower half of the industry: CHR underperforms 77.78% of its industry peers.
CHR has a debt to FCF ratio of 2.43. This is a good value and a sign of high solvency as CHR would need 2.43 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.43, CHR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CHR has a Debt/Equity ratio of 0.55. This is a neutral value indicating CHR is somewhat dependend on debt financing.
CHR's Debt to Equity ratio of 0.55 is amongst the best of the industry. CHR outperforms 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 2.43 | ||
| Altman-Z | 0.65 |
ROIC/WACC0.82
WACC8.36%
2.3 Liquidity
CHR has a Current Ratio of 0.95. This is a bad value and indicates that CHR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CHR (0.95) is better than 66.67% of its industry peers.
CHR has a Quick Ratio of 0.95. This is a bad value and indicates that CHR is not financially healthy enough and could expect problems in meeting its short term obligations.
CHR has a Quick ratio of 0.69. This is comparable to the rest of the industry: CHR outperforms 44.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.69 |
3. Growth
3.1 Past
The earnings per share for CHR have decreased strongly by -3069.51% in the last year.
The Revenue for CHR has decreased by -16.43% in the past year. This is quite bad
The Revenue has been growing slightly by 0.56% on average over the past years.
EPS 1Y (TTM)-3069.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2915.23%
Revenue 1Y (TTM)-16.43%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-16.21%
3.2 Future
Based on estimates for the next years, CHR will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.29% on average per year.
The Revenue is expected to grow by 1.79% on average over the next years.
EPS Next Y85.62%
EPS Next 2Y19.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.29%
Revenue Next 2Y-1.93%
Revenue Next 3Y1.79%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CHR. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 9.66, the valuation of CHR can be described as very reasonable.
CHR's Price/Forward Earnings ratio is rather cheap when compared to the industry. CHR is cheaper than 88.89% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. CHR is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 9.66 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CHR is valued cheaper than 88.89% of the companies in the same industry.
100.00% of the companies in the same industry are more expensive than CHR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.64 | ||
| EV/EBITDA | 4.04 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CHR's earnings are expected to grow with 19.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.29%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for CHR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:CHR (3/7/2025, 7:00:00 PM)
20.79
+0.25 (+1.22%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)
Earnings (Next)
Inst Owners1.95%
Inst Owner ChangeN/A
Ins Owners1.18%
Ins Owner ChangeN/A
Market Cap560.08M
Analysts78.18
Price Target28.12 (35.26%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-10.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.71%
Min Revenue beat(2)-7.96%
Max Revenue beat(2)-3.46%
Revenue beat(4)1
Avg Revenue beat(4)-3.96%
Min Revenue beat(4)-10.27%
Max Revenue beat(4)5.86%
Revenue beat(8)4
Avg Revenue beat(8)-1.03%
Revenue beat(12)6
Avg Revenue beat(12)0.34%
Revenue beat(16)9
Avg Revenue beat(16)5.82%
PT rev (1m)626.73%
PT rev (3m)637.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)602.21%
EPS NY rev (3m)603.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.91%
Revenue NY rev (3m)-0.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 9.66 | ||
| P/S | 0.4 | ||
| P/FCF | 2.64 | ||
| P/OCF | 2.11 | ||
| P/B | 1.09 | ||
| P/tB | 1.11 | ||
| EV/EBITDA | 4.04 |
EPS(TTM)-9.74
EYN/A
EPS(NY)2.15
Fwd EY10.35%
FCF(TTM)7.87
FCFY37.87%
OCF(TTM)9.84
OCFY47.32%
SpS52.15
BVpS19
TBVpS18.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -16.53% | ||
| ROE | -51.9% | ||
| ROCE | 9.2% | ||
| ROIC | 6.82% | ||
| ROICexc | 8.69% | ||
| ROICexgc | 8.78% | ||
| OM | 6.78% | ||
| PM (TTM) | N/A | ||
| GM | 64.61% | ||
| FCFM | 15.1% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover0.87
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 2.43 | ||
| Debt/EBITDA | 1.34 | ||
| Cap/Depr | 45.44% | ||
| Cap/Sales | 3.76% | ||
| Interest Coverage | 1.21 | ||
| Cash Conversion | 125.19% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.69 | ||
| Altman-Z | 0.65 |
F-Score6
WACC8.36%
ROIC/WACC0.82
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3069.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2915.23%
EPS Next Y85.62%
EPS Next 2Y19.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.43%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-16.21%
Revenue Next Year-2.29%
Revenue Next 2Y-1.93%
Revenue Next 3Y1.79%
Revenue Next 5YN/A
EBIT growth 1Y-63.67%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year97.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.3%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-11.57%
OCF growth 3Y12.73%
OCF growth 5Y0.25%